Evommune (EVMN) EBITDA (2024 - 2026)
Evommune (EVMN) reported EBITDA of -$24.0 million for Q1 2026, down 59.35% year-over-year from -$58.9 million in Q1 2025, and up 19.39% quarter-over-quarter from -$29.7 million in Q4 2025.
Evommune (EVMN) EBITDA (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of EBITDA data on file, last reported at -$24.0 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$24.0 million, down 59.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$82.0 million (changed N/A YoY), and the FY2025 annual result was -$81.1 million, down 15.79% from the prior year.
- EBITDA climbed to -$24.0 million in Q1 2026 per EVMN's latest filing, from -$29.7 million in the prior quarter.
- Over five years, EBITDA peaked at -$13.3 million in Q3 2025 and troughed at -$29.7 million in Q4 2025.
- A 3-year average of -$20.0 million and a median of -$19.0 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2025 and 2026: EBITDA climbed 19.31% in 2025, then plunged 59.35% in 2026.
- A 3-year view of EBITDA shows it stood at -$21.5 million in 2024, then tumbled by 38.51% to -$29.7 million in 2025, then gained by 19.39% to -$24.0 million in 2026.
- Business Quant data shows EVMN's EBITDA at -$24.0 million in Q1 2026, -$29.7 million in Q4 2025, and -$13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | -23.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -29.72 Mn |
| Sep 30, 2025 | -13.33 Mn |
| Mar 31, 2025 | -15.03 Mn |
| Dec 31, 2024 | -21.45 Mn |
| Sep 30, 2024 | -16.52 Mn |